ReachMD

Episodes 1-15 of 15

• • 

    

    Kristi K. Orbaugh, MSN, NP, AOCN®

    Peer

  • 

    

    Val R. Adams, PharmD, FCCP, BCOP, FHOPA

    Peer

  • 

    

    Theresa W. Gillespie, PhD, MA, RN, FAAN

    Peer

  0

  

  RestartResume

  Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer

  Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer

  1.00 credits

• • 

    

    D. Ross Camidge, MD, PhD

    Peer

  3

  

  RestartResume

  Improving the Quality of Care for Patients Harboring ALK+ NSCLC

  Improving the Quality of Care for Patients Harboring ALK+ NSCLC

  0.50 credits

• • 

    

    Monica L. Baskin, PhD

    Peer

  • 

    

    Josep M. Llovet, MD, PhD

    Peer

  3

  

  RestartResume

  Advocating for Action in HCC: Delivering Impartial and Personalized Care

  Advocating for Action in HCC: Delivering Impartial and Personalized Care

  1.00 credits

• • 

    

    Yohann Loriot, MD, PhD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  10

  

  RestartResume

  Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies

  Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies

  1.00 credits

• • 

    

    Yohann Loriot, MD, PhD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  12

  

  RestartResume

  Princípios e estratégias práticas para imunoterapia em malignidades geniturinárias

  Princípios e estratégias práticas para imunoterapia em malignidades geniturinárias

  1.00 credits

• • 

    

    Yohann Loriot, MD, PhD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  2

  

  RestartResume

  Principios y estrategias prácticas para realizar inmunoterapia en neoplasias genitourinarias malignas

  Principios y estrategias prácticas para realizar inmunoterapia en neoplasias genitourinarias malignas

  1.00 credits

• • 

    

    Ajay K. Gopal, MD

    Peer

  0

  

  RestartResume

  Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma

  Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma

  0.25 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Pelin Cinar, MD, MS

    Peer

  • 

    

    Malika Fair, MD, MPH, FACEP

    Peer

  8

  

  RestartResume

  The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

  The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

  1.00 credits

• • 

    

    Timothy Fenske, MD, MS

    Peer

  5

  

  RestartResume

  Part 2: Improving Risk-based Management Decisions in Follicular Lymphoma

  Part 2: Improving Risk-based Management Decisions in Follicular Lymphoma

  0.50 credits

• • 

    

    Timothy Fenske, MD, MS

    Peer

  0

  

  RestartResume

  Part 1: Improving Risk-based Management Decisions in Follicular Lymphoma

  Part 1: Improving Risk-based Management Decisions in Follicular Lymphoma

  0.50 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  5

  

  RestartResume

  Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  5

  

  RestartResume

  Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Richard S. Finn, MD

    Peer

  • 

    

    Amit Singal, MD, MS

    Peer

  11

  

  RestartResume

  Multidisciplinary Perspectives in Advanced HCC:  A Focus on Immune Checkpoint Inhibitors

  Multidisciplinary Perspectives in Advanced HCC:  A Focus on Immune Checkpoint Inhibitors

  0.75 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  6

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era

  1.00 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  8

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series

  0.50 credits